Price controls on pharmaceuticals will not lower prices and will lead to fewer future cures.
Sen. Elizabeth Warren Wants the Government to Steal IP and Stifle Future Pharmaceutical Innovation
Sen. Elizabeth Warren (D-Mass.) urges HHS to steal and redistribute intellectual property as a mechanism to lower drug prices.
President Biden Again Tries to Undermine U.S. Biomedical Innovation
President Biden’s support of intellectual property waivers threatens development of future life-saving medicines.
Price Controls in the BBBA Will Destroy the Development of Future Cures
The price controls found in the BBBA leave patients worse off.
Price Controls Will Create an Invisible Graveyard of Americans
The Build Back Better Act will cost lives by devastating the development of future cures.
What’s Worse than Most Favored Nation – Budget Reconciliation
The Biden administration proposes to recind President Trump’s Most Favored Nation Policy.
Biden Budget Offers Potential Oversight Tool on 340B Program
The Biden administration’s budget includes new enforcement tools for oversight of the 340B program but the details will matter.
Most Favored Nation Policy Is Unfavorable to U.S. Biopharmaceutical Research
Back in September, President Trump signed an Executive Order ordering the Department of Health and Human Services to implement a most favored nation (MFN) policy for pharmaceutical reimbursement in Medicare.
HHS Says NO to AGs Trying to Steal Patents
HHS sends a clear message to AGs regarding march-in rights.
CAGW to HHS: Say No to State AGs Demands
On Tuesday, state attorneys general from across the country and two U.S. territories demanded that the federal government steal the patent for remdesivir.